These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22544193)

  • 21. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV drug resistance early warning indicators in Namibia for public health action.
    Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
    PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
    Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
    Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
    BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.
    Hingankar NK; Thorat SR; Deshpande A; Rajasekaran S; Chandrasekar C; Kumar S; Srikantiah P; Chaturbhuj DN; Datkar SR; Deshmukh PS; Kulkarni SS; Sane S; Reddy DC; Garg R; Jordan MR; Kabra S; Tripathy SP; Paranjape RS
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S348-54. PubMed ID: 22544202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
    HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of early warning indicators for HIV/AIDS in 42 outpatient clinics in 25 northern provinces of Vietnam.
    Le HT; Doan LTT; Pham DK; Ngoc Hoang Le Q; Phuc Do H; Nguyen HLT
    F1000Res; 2017; 6():517. PubMed ID: 29904573
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
    Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y
    Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveys of transmitted HIV drug resistance in 7 geographic Regions in China, 2008-2009.
    Liao L; Xing H; Dong Y; Qin G; Ma Y; Lu H; Chen L; Zhang L; Osborne C; Seguy N; Wei D; Sun F; Yang J; Ruan Y; Shao Y
    Clin Infect Dis; 2012 May; 54 Suppl 4():S320-3. PubMed ID: 22544196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
    Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
    Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of HIV drug resistance and public health implications in low- and middle-income countries.
    Bertagnolio S; De Luca A; Vitoria M; Essajee S; Penazzato M; Hong SY; McClure C; Duncombe C; Jordan MR
    Antivir Ther; 2012; 17(6):941-53. PubMed ID: 22898622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV/AIDS profile and realities at a regional antiretroviral therapy clinic in Jerusalem: 12 years analysis.
    Elinav H; Pops KO; Shasha D; Korem M; Hauzi-Bashan M; Grossman Z; Maayan S
    Scand J Infect Dis; 2012 Jan; 44(1):65-9. PubMed ID: 21923627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
    Shah B; Walshe L; Saple DG; Mehta SH; Ramnani JP; Kharkar RD; Bollinger RC; Gupta A
    Clin Infect Dis; 2007 May; 44(9):1235-44. PubMed ID: 17407045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress of the National Pediatric Free Antiretroviral Therapy program in China.
    Zhao Y; Sun X; He Y; Tang Z; Peng G; Liu A; Qiao X; Li H; Chen Z; Dou Z; Ma Y; Liu Z; Zhang F
    AIDS Care; 2010 Oct; 22(10):1182-8. PubMed ID: 20665285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
    Wadonda-Kabondo N; Hedt BL; van Oosterhout JJ; Moyo K; Limbambala E; Bello G; Chilima B; Schouten E; Harries A; Massaquoi M; Porter C; Weigel R; Hosseinipour M; Aberle-Grasse J; Jordan MR; Kabuluzi S; Bennett DE
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S355-61. PubMed ID: 22544203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
    Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
    PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.